Joe Horvatinovich

Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma

Robert A. Figlin, Nizar M. Tannir, Robert G. Uzzo et al. · Clinical Cancer Research · 2020 · 78 citations · Full text

Medicine, Immunology, Oncology +17

Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes

Joe Horvatinovich, Elizabeth W. Grogan, Marcus S. Norris et al. · The Journal of Immunology · 2017 · 62 citations · Full text

Life Sciences, Cell Biology, Immunology +10

Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion

Irina Y. Tcherepanova, Melissa D. Adams, Xiaorong Feng et al. · BMC Molecular Biology · 2008 · 57 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Cytokine Maturation Followed by CD40L mRNA Electroporation Results in a Clinically Relevant Dendritic Cell Product Capable of Inducing a Potent Proinflammatory CTL Response

David M. Calderhead, Mark DeBenedette, Helen Ketteringham et al. · Journal of Immunotherapy · 2008 · 44 citations

Life Sciences, Cell Biology, Immunology +17

Priming of a Novel Subset of CD28+ Rapidly Expanding High-Avidity Effector Memory CTL by Post Maturation Electroporation-CD40L Dendritic Cells Is IL-12 Dependent

Mark DeBenedette, David M. Calderhead, Helen Ketteringham et al. · The Journal of Immunology · 2008 · 30 citations · Full text

Life Sciences, Cell Biology, Immunology +17